Thomas P. Lynch serves as Executive at Orexigen Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Thomas P. Lynch has executed 4 insider transactions totaling $6.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 7, 2025 involved transacting 600 shares valued at $0.
Thomas P. Lynch currently holds 600 shares of Orexigen Therapeutics, Inc. (OREX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas P. Lynch has been a net buyer of OREX stock. They have purchased $6.0K and sold $0 worth of shares.
Thomas P. Lynch's most recent insider trade was on Nov 7, 2025, when they sold 600 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 7, 2025 | BLLN | $6.0K | Purchase | 100 | $60.00 | Discretionary |
| May 31, 2017 | OREX | $2.6K | Award | 1,704 | $1.55 | Discretionary |